| 3,858 | 111 | 14 |
| 下载次数 | 被引频次 | 阅读次数 |
<正>我国原发性肝癌的发病率和病死率均占全球的50%以上,且有其自身特点。治疗方法众多,缺少统一规范。为此,我国卫生部医政司组织多学科专家进行深入研讨,修订了《原发性肝癌诊疗规范》,已正式公布,期望能积极推动我国原发性肝癌(主要
Abstract：1 ShindohJ,HasegawaK,InoueY,IshizawaT,NagataR,et al.Risk factorsof post-operative recurrence and adequate surgical approach to im-prove long-term outcomes of hepatocellular carcinoma.HPB(Ox-ford),2013,15(1):31-9.
2 Casaccia M,Andorno E,Di Domenico S,et al.Laparoscopic resec-tion of hepatocellular carcinoma.Considerations on lesions in the pos-terosuperior segments of the liver.Ann Ital Chir,2012,83(6):503-8.
3单二波,刘会春,周磊,等.RFA联合TACE治疗中晚期肝癌的疗效观察.肝胆外科杂志,2012,20(5):362-366.
4 Germani G,Pleguezuelo M,Gurusamy K,et al.Clinical outcomes ofradiofrequency ablation,percutaneous alcohol and acetic acid injec-tion for hepatocelullar carcinoma:a meta-analysis.J Hepatol,2010,52(3):380-8.
5 Kudo M,Ueshima K,Arizumi T.Real-life clinical practice withsorafenib in advanced hepatocellular carcinoma:a single-center expe-rience.Dig Dis,2012,30(6):609-16.
基本信息:
DOI：
中图分类号:R735.7
引用信息:
[1]刘会春.中国原发性肝癌治疗指南解读[J].肝胆外科杂志,2013,21(01):12-14.
基金信息: